Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(36 sites)
United States
Banner Health - MD Anderson Cancer Center, Gilbert, Arizona Christiana Care Hospital - Helen F Graham Cancer Center, Newark, Delaware Napa Research, Pompano Beach, Florida Beth Israel Deaconess Medical Center, Boston, Massachusetts Regional Cancer Care Associates, Hackensack, New Jersey